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Stroke is a clinically heterogeneous entity. Based on the heart 
disease and stroke statistics from the American Heart Associa-
tion, ischemic stroke, intracerebral hemorrhage, and sub-
arachnoid hemorrhages account for 87%, 10%, and 3% of all 
strokes, respectively.1 Approximately a quarter of all ischemic 
strokes are cryptogenic.2 Moreover, patients with atrial fibril-
lation (AF) had severe clinical presentation or sequelae of ce-
rebral infarction compared to those without AF; hence, early 
detection of AF significantly improves patient prognosis and 
reduces the overall healthcare costs.3 Previous studies have re-
ported that premature atrial contractions (PACs) and non-sus-
tained atrial tachycardia (NSAT) observed on 24-hour Holter 
monitoring may predict undiagnosed AF.4,5 We investigated 
whether frequent PACs predicted new-onset AF and recurrent 
stroke in cryptogenic stroke patients without previously diag-
nosed AF.
A total of 390 patients with concomitant NSAT from 2091 pa-
tients who were diagnosed with acute ischemic stroke without 
intracardiac thrombi were included in the study between Janu-
Frequent Premature Atrial Contractions as a Poor 
Prognostic Factor in Cryptogenic Stroke Patients with 
Concomitant Non-Sustained Atrial Tachycardia
Jung-Joon Cha1, Kyung-Yul Lee2, Hyemoon Chung3, In-Soo Kim4, Eui-Young Choi4,  
Pil-Ki Min4, Young Won Yoon4, Byoung Kwon Lee4, Bum-Kee Hong4,  
Se-Joong Rim4, Hyuck Moon Kwon4, and Jong-Youn Kim4
1Division of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul; 
2Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; 
3Department of Cardiology, Department of Internal Medicine, Kyung Hee University, Seoul; 
4Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
In cryptogenic stroke patients, early detection of new-onset atrial fibrillation (AF) and recurrent stroke is required to prevent poor 
clinical outcomes. Therefore, we investigated the predictors of new-onset AF and recurrent stroke in cryptogenic stroke patients 
without previously diagnosed AF. In total, 390 patients who were diagnosed with stroke and non-sustained atrial tachycardia 
(NSAT) on 24-hour Holter monitoring were followed up to assess new-onset AF and recurrent stroke. The 5-year event-free sur-
vival as well as the predictors of recurrent stroke or new-onset AF were investigated. Based on receiver operating characteristic 
analysis, frequent premature atrial contractions (PACs) were defined as PACs >44 beats/day. The median follow-up period was 35 
months. The composite event rate was 11.5%. In Kaplan-Meier analysis, the 5-year cumulative incidence of composite events was 
higher in cryptogenic stroke patients with frequent PACs than in those without frequent PACs. Multivariate analysis revealed that 
current smoking, increased left atrial volume index, and frequent PACs were poor prognostic predictors of composite event, and 
frequent PACs were an independent poor prognostic factor of new-onset AF in cryptogenic stroke patients. Therefore, frequent 
PACs might be associated with poor clinical outcomes (new-onset AF and recurrent stroke) in cryptogenic stroke patients with 
concomitant NSAT.
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ary 2009 and December 2012. All of the patients were not diag-
nosed with AF before the first episode of acute ischemic stroke. 
The diagnosis of stroke was based on the International Classi-
fication of Diseases, Ninth Revision. For neurological evalua-
tion, patients underwent magnetic resonance imaging or com-
puted tomography. Brain magnetic resonance imaging and 
angiography were performed to exclude patients with athero-
sclerotic or cardioembolic strokes and structural heart diseas-
es. In addition, patients with intracardiac thrombi were exclud-
ed by transesophageal echocardiography. Therefore, in the 
Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classi-
fication,6 etiologies of the enrolled patients were small vessel 
disease and other determined and undetermined etiologies. 
NSAT was diagnosed by 24-hour Holter monitoring on current 
admission. NSAT was defined as ≥3 consecutive PACs with a 
heart rate of >100 beats/min for <30 s. PAC was defined based 
on the following electrocardiographic parameters: 1) a short-
ened RR interval (≥25% reduction in interval duration), 2) oc-
currence of a P wave, and 3) QRS width <0.12 s. Within 7 days of 
admission, all of the enrolled patients underwent transthoracic 
echocardiography, transesophageal echocardiography, and 
24-hour Holter monitoring. The enrolled patients were admit-
ted at three tertiary hospitals (Severance Hospital, Gangnam 
Severance Hospital, and Kyung Hee University Hospital). This 
study complied with the Declaration of Helsinki and was ap-
proved by the Institutional Review Board of the Gangnam Sev-
erance Hospital, Seoul, South Korea (3-2020-0260). Written in-
formed consent was obtained from all patients. 
The exclusion criteria were as follows: 1) history of stroke or 
transient ischemic attack; 2) history of a brain hemorrhage, 
brain tumor, and cerebrovascular malformations; 3) known 
tachyarrhythmias, including supraventricular tachyarrhyth-
mia; 4) status post of a permanent pacemaker; 5) presence of 
atherosclerotic plaques involving the aorta or aortic arch and 
the carotid artery; 6) history of structural heart disease; 7) sys-
tolic dysfunction [ejection fraction (EF); <50%]; and 8) history 
of neoplasm. 
Patients were categorized into those without events (n=345) 
and those with events (n=45). Electronic medical records of the 
patients and relevant data were collected. After the first isch-
emic stroke event, the enrolled patients underwent standard 
ECG, 24-hour Holter monitoring, and echocardiography to 
identify cardioembolic sources of stroke. After that, antiplate-
let agents (aspirin, clopidogrel, or triflusal) were prescribed. 
Recurrent stroke was defined as the occurrence of neurologi-
cal symptoms associated with objective evidence of lesions on 
brain imaging. New-onset AF is a working diagnosis in patients 
without a history of AF, until the pattern of AF can be defined 
more precisely. After enrollment, all of the patients regularly 
visited the outpatient clinics after discharge to check for symp-
toms and undergo a standard 12-lead ECG recording every 3 
months. Based on a standard 12-lead ECG recording or a sin-
gle-lead ECG tracing lasting 30 seconds, heart rhythm with no 
discernible repeating P waves and irregular RR intervals (when 
atrioventricular conduction is not impaired) was diagnosed as 
clinical AF.
According to the current American Society of Echocardiogra-
phy guidelines, all of the patients underwent Doppler echocar-
diography to measure the following echo parameters: 1) peak 
early (E); 2) late diastolic mitral inflow velocities; 3) early dia-
stolic mitral annulus peak velocity (e') from the septal aspect 
of the mitral annulus in the apical four-chamber view; 4) E/e' 
ratio, with an E/e' ratio of >14 defined as the presence of dia-
stolic dysfunction7; 5) EF, which was calculated by Modified 
Simpson rule; 6) the left atrial (LA) anteroposterior diameter, 
which was measured in a parasternal long-axis view at end-sys-
tole to determine the left atrium size; 7) LA volume, which was 
measured by the ellipse method from the apical four-chamber 
and parasternal long-axis views at ventricular end-systole; and 
8) LA volume index (LAVi), which was used to adjust LA vol-
ume regarding body surface area.
Categorical and continuous variables are presented as num-
bers (percentages) and mean±standard deviation, respective-
ly. Baseline clinical characteristics were compared between 
patients with and without composite events using Student’s t-
test for continuous variables and the chi-square test for cate-
gorical variables. A p-value <0.05 was considered statistically 
significant. The Youden index based on receiver operating char-
acteristic was used to determine the optimal cutoff value for 
composite events. Based on the area under the receiver oper-
ating characteristic curve value (0.602), PACs >44 beats/day 
were defined as frequent PACs (sensitivity: 71% and specifici-
ty: 52%). Kaplan-Meier survival curves and log-rank test were 
used to compare the 5-year cumulative incidence of compos-
ite events between patients with and without frequent PACs. 
Univariate and multivariate Cox proportional hazards regres-
sion analyses were performed to determine independent poor 
predictors of composite events. Variables with a p-value <0.20 
in univariate analysis or those considered relevant predictors 
of clinical events were included in the multivariate analysis. All 
statistical analyses were performed using the SPSS software 
ver. 25.0 (IBM Corp., Armonk, NY, USA).
The mean age of the 390 patients was 67 years. No statistical-
ly significant intergroup differences were noted in the base-
line clinical characteristics, including the mean age (p=0.110). 
However, compared to patients without clinical events, those 
with clinical events had a larger LA diameter (36.2 mm vs. 37.7 
mm, p= 0.044), LA volume (40.5 mm3 vs. 46.1 mm3, p=0.003), 
and LAVi (24.1 mm3/m2 vs. 28 mm3/m2, p=0.005) (Table 1). The 
median follow-up period was 35 months, and the composite 
event rate was 11.5% (45/390). With regard to individual clini-
cal events, the rate of new-onset AF was 3.1%, and that of stroke 
recurrence was 9%. Kaplan-Meier analysis revealed that the 
5-year cumulative incidence of composite events (new-onset 
AF and recurrent stroke) was significantly higher among cryp-
togenic stroke patients with frequent PACs than among those 
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without frequent PACs (15.2% vs. 7.2%, log-rank p=0.003) (Fig. 
1A). In addition, individual Kaplan-Meier analysis revealed 
that compared to cryptogenic stroke patients without frequent 
PACs, those with frequent PACs had a higher rate for both new-
onset AF (4.8% vs. 1.1%, log-rank p=0.006) (Fig. 1B) and recur-
rent stroke (11.4% vs. 6.1%, log-rank p=0.031) (Fig. 1C).
Univariate and multivariate Cox proportional hazard regres-
sion analyses were performed to investigate the predictors of 
composite events in cryptogenic stroke patients (Table 2). Uni-
variate analysis revealed that age [hazards ratio (HR): 1.03, 95% 
confidence interval (CI): 1.00–1.06, p=0.049], LAVi (HR: 1.07, 
95% CI: 1.03–1.10, p=0.002), and frequent PACs (HR: 2.62, 95% 
CI: 1.37–5.02, p=0.004) were poor predictors for composite event 
in cryptogenic stroke patients. Multivariate analysis revealed 
that cigarette smoking status (HR: 2.07, 95% CI: 1.12–3.84, p= 
0.021), LAVi (HR: 1.05, 95% CI: 1.01–1.08, p=0.006), and frequent 
PACs (HR: 2.30, 95% CI: 1.16–4.56, p=0.017) were independent 
poor prognostic factors in cryptogenic stroke patients with con-
comitant NSAT after adjusting for confounders such as age, sex, 
EF, diastolic dysfunction (E/e' >14), LAVi, hypertension, diabe-
tes, coronary artery disease, chronic kidney disease, cigarette 
smoking status, and frequent PACs. Additionally, multivariate 
analysis for individual events revealed that compared with 
cryptogenic stroke patients without frequent PACs, those with 
frequent PACs had a higher risk of new-onset AF (HR: 5.34, 
95% CI: 1.10–25.85, p=0.037) but not of stroke recurrence (HR: 
1.99, 95% CI: 0.94–4.20, p=0.072).
The main findings of this study are as follows: 1) frequent 
PACs are a poor prognostic factor for clinical outcomes in cryp-
togenic stroke patients and 2) frequent PACs are associated 
with new-onset AF in cryptogenic stroke patients. In context, 
we suggest that cryptogenic stroke patients with risk factors for 
poor predictors should be considered for close and prolonged 
follow-up with cardiac rhythm monitoring to improve clinical 
outcomes.
We found that frequent PACs were a poor prognostic factor 
for clinical outcomes in cryptogenic stroke patients with NSAT 
and no previously diagnosed AF. The definition of frequent PACs 
remains unclear. Previous studies have defined frequent PACs 
based on their study results, which represent a subjective inter-
pretation8-10; nevertheless, compared to cryptogenic stroke pa-
tients without frequent PACs, those with frequent PACs had 
poor clinical outcomes.8-10 Another study reported that the PAC 
burden detected by Holter monitoring might be associated 
with clinical outcomes.11
Although various studies have reported an association between 
frequent PACs and poor clinical outcome, the exact pathomech-
anism remains unclear. In our study, frequent PACs were asso-
ciated with poor clinical outcomes in composite event and new-
onset AF, but not with recurrent stroke. Plausible reasons may 




No event (n=345) Event (n=45)
Age (yr) 66.7±11.9 66.4±11.7 69.4±13.0 0.110
Male sex 219 (56.2) 195 (56.5) 24 (53.3) 0.806
Hypertension 273 (70.0) 237 (68.7) 36 (80.0) 0.167
Diabetes 107 (27.4) 99 (28.7) 8 (17.8) 0.172
Dyslipidemia 160 (41.0) 143 (41.4) 17 (37.8) 0.757
Chronic kidney disease 17 (4.4) 13 (3.8) 4 (8.9) 0.232
Vascular disease 12 (3.1) 10 (2.9) 2 (4.4) 0.916
Coronary artery disease 41 (10.5) 37 (10.7) 4 (8.9) 0.905
Cigarette smokers 148 (37.9) 127 (36.8) 21 (46.7) 0.264
Echocardiographic parameters
LA diameter (mm) 36.4±4.5 36.2±4.4 37.7±5.0 0.044
LA volume (mm3) 41.2±11.8 40.5±11.5 46.1±12.9 0.003
LA volume index (mm3/m2) 24.5±6.9 24.1±6.5 28.0±8.6 0.005
LVEF (%) 66.6±8.8 66.7±8.7 66.0±9.1 0.612
LV mass index (g/m2) 106.1±28.9 105.3±27.1 112.4±40.2 0.279
E/e’ 12.0±4.5 11.8±4.1 13.5±6.2 0.082
PACs (n) 541.0±2565.7 537.4±2608.8 568.5±2233.7 0.939
Frequent PACs 210 (53.8) 178 (51.6) 32 (71.1) 0.017
Medication
Aspirin 301 (77.2) 264 (76.5) 37 (82.2) 0.504
Triflusal 203 (52.1) 182 (52.8) 21 (46.7) 0.542
Clopidogrel 30 (7.7) 29 (8.4) 1 (2.2) 0.243
LA, left atrial; LV, left ventricular; LVEF, left ventricular ejection fraction; PAC, premature atrial contractions.
Data are presented as n (%).
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be that PACs are known precursors of AF, which is a potential 
risk factor for stroke.5,12 Previous studies have reported an asso-
ciation between PACs and AF in cryptogenic stroke patients12-14 
and proved that frequent PACs or consecutive supraventricular 
extrasystoles, such as NSAT, are associated with a higher prev-
alence of AF.12-14 In our results, frequent PACs was defined as 
PACs >44 beats/day using the Youden index based on the re-
ceiver operating characteristic. The cut-off value used in our 
study was relatively small compared to that in the aforemen-
tioned study. However, despite the relatively small number of 
PAC, our results revealed that patients with frequent PACs had 
a potential risk of hidden AF. Therefore, intensive observation 
with a 12-lead ECG recording or the usage of a loop recorder for 
patients who have frequent PAC may offer better clinical out-
comes by early detection of new-onset AF.
In addition, our results revealed that increased LAVi was a 
poor predictor of clinical outcomes. Previous studies have sug-
gested LAVi as a risk factor for cardioembolic stroke.15,16 Also, 
Atrial stretch17 and atrial tissue alterations18 in an enlarged left 
atrium are associated with disturbances in impulse propaga-
tion in patients with AF, suggesting that left atrium enlargement 
may increase the atrial ectopy rate and, consequently, the risk 
of stroke.19 In addition, the association between smoking status 
and recurrent stroke is statistically significant. 
The smoking aggravates atherosclerosis and stroke occur-
rence by an increase of oxidative stress, endothelial dysfunc-
tion, and inflammation.20,21 In addition, smoking increases the 
risk of recurrent stroke.22 Furthermore, we suggest that patients 
with the abovementioned risk factors should be considered as 
having a high risk of poor clinical outcomes. Therefore, close 
monitoring of frequent PACs with 24-hour Holter monitoring 
or wearable devices for detecting arrhythmia may contribute 
to better clinical outcomes in cryptogenic stroke patients.
This study had some limitations. First, since this was a retro-
spective study based on data from three tertiary referral hospi-
tals, the possibility of selection and referral bias cannot be ex-
cluded. Second, the study population was relatively small, and 
the study lacked follow-up 24-hour Holter monitoring. Third, 
the statistical model in the multivariate analysis may not have 
accurately analyzed unmeasured confounding factors, such as 
the patients’ general health condition and the three-dimension-
al techniques used in transthoracic echocardiography. There-
fore, frequent PACs are significantly associated with poor clini-
cal outcomes in cryptogenic stroke patients with concomitant 
NSAT.
Fig. 1. Kaplan-Meier survival curves. (A) Composite clinical events. (B) New-
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Table 2. Adjusted Multivariate Risk of Frequent PACs for Subsequent 5-Year Clinical Events
Event rate at 5 year (unadjusted)
Adjusted HR of frequent PACs (95% CI) p valueWithout frequent PACs 
(n=180)
With frequent PACs 
(n=210)
Composite events 7.2% (13) 15.2% (32) 2.30 (1.16–4.56) 0.017
New-onset atrial fibrillation 1.1% (2) 4.8% (10) 5.34 (1.10–25.85) 0.037
Recurrent stroke 6.1% (11) 11.4% (24) 1.99 (0.94–4.20) 0.072
HR, hazard ratio; PAC, premature atrial contractions; CI, confidence interval.
Rates are Kaplan-Meier estimates at 5 year (number of events). P-value corresponds to the adjusted HR (95% CI). All clinical endpoints were adjusted by age, sex.
EF, diastolic dysfunction (E/e’ >14), LAVi, hypertension, diabetes, coronary artery disease, chronic kidney disease, cigarette smoking status, and frequent PACs. 
969
Jung-Joon Cha, et al.
https://doi.org/10.3349/ymj.2020.61.11.965
AUTHOR CONTRIBUTIONS
Conceptualization: Kyung-Yul Lee and Jong-Youn Kim. Data curation: 
Kyung-Yul Lee, Hyemoon Chung, In-Soo Kim, Eui-Young Choi, Pil-Ki 
Min, Young Won Yoon, Byoung Kwon Lee, Bum-Kee Hong, Se-Joong Rim, 
Hyuck Moon Kwon, and Jong-Youn Kim. Formal analysis: Jung-Joon Cha 
and Jong-Youn Kim. Funding acquisition: Jong-Youn Kim. Investiga-
tion: Jung-Joon Cha, Kyung-Yul Lee, and Jong-Youn Kim. Methodolo-
gy: Jung-Joon Cha and Jong-Youn Kim. Project administration: Jong-
Youn Kim. Resources: Kyung-Yul Lee and Jong-Youn Kim. Software: 
Jung-Joon Cha. Supervision: Kyung-Yul Lee, Hyemoon Chung, In-Soo 
Kim, Eui-Young Choi, Pil-Ki Min, Young Won Yoon, Byoung Kwon Lee, 
Bum-Kee Hong, Se-Joong Rim, Hyuck Moon Kwon, and Jong-Youn 
Kim. Validation: Jung-Joon Cha, Kyung-Yul Lee, and Jong-Youn Kim. 
Visualization: Jung-Joon Cha. Writing—original draft: Jung-Joon Cha. 









Young Won Yoon https://orcid.org/0000-0002-0907-0350
Byoung Kwon Lee https://orcid.org/0000-0001-9259-2776
Bum-Kee Hong https://orcid.org/0000-0002-6456-0184
Se-Joong Rim https://orcid.org/0000-0002-7631-5581
Hyuck Moon Kwon https://orcid.org/0000-0001-9901-5015
Jong-Youn Kim https://orcid.org/0000-0001-7040-8771
REFERENCES
1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, 
Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: 
A Report From the American Heart Association. Circulation 2019; 
139(10):e56-e528.
2. Saver JL. Clinical Practice. Cryptogenic stroke. N Engl J Med 2016; 
374:2065-74. 
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. 
Prevalence of diagnosed atrial fibrillation in adults: national impli-
cations for rhythm management and stroke prevention: the AnTi-
coagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. 
JAMA 2001;285:2370-5.
4. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, 
Haase B, et al. Enhanced detection of paroxysmal atrial fibrillation 
by early and prolonged continuous holter monitoring in patients 
with cerebral ischemia presenting in sinus rhythm. Stroke 2010;41: 
2884-8.
5. Wallmann D, Tüller D, Kucher N, Fuhrer J, Arnold M, Delacretaz E. 
Frequent atrial premature contractions as a surrogate marker for 
paroxysmal atrial fibrillation in patients with acute ischaemic stroke. 
Heart 2003;89:1247-8.
6. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon 
DL, et al. Classification of subtype of acute ischemic stroke. Defini-
tions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 
in Acute Stroke Treatment. Stroke 1993;24:35-41.
7. Vinther KH, Tveskov C, Möller S, Auscher S, Osmanagic A, Egstrup 
K. Excessive premature atrial complexes and the risk of recurrent 
stroke or death in an ischemic stroke population. J Stroke Cerebro-
vasc Dis 2017;26:1163-70.
8. Binici Z, Intzilakis T, Nielsen OW, Køber L, Sajadieh A. Excessive 
supraventricular ectopic activity and increased risk of atrial fibril-
lation and stroke. Circulation 2010;121:1904-11.
9. Larsen BS, Kumarathurai P, Falkenberg J, Nielsen OW, Sajadieh A. 
Excessive atrial ectopy and short atrial runs increase the risk of 
stroke beyond incident atrial fibrillation. J Am Coll Cardiol 2015; 
66:232-41.
10. Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos 
GD, Barone D, et al. Echocardiographic reference ranges for nor-
mal cardiac Doppler data: results from the NORRE Study. Eur Heart 
J Cardiovasc Imaging 2015;16:1031-41.
11. Inohara T, Kohsaka S, Okamura T, Watanabe M, Nakamura Y, Hi-
gashiyama A, et al. Long-term outcome of healthy participants with 
atrial premature complex: a 15-year follow-up of the NIPPON 
DATA 90 cohort. PLoS One 2013;8:e80853. 
12. Kochhäuser S, Dechering DG, Dittrich R, Reinke F, Ritter MA, Ram-
tin S, et al. Supraventricular premature beats and short atrial runs 
predict atrial fibrillation in continuously monitored patients with 
cryptogenic stroke. Stroke 2014;45:884-6. 
13. Chong BH, Pong V, Lam KF, Liu S, Zuo ML, Lau YF, et al. Frequent 
premature atrial complexes predict new occurrence of atrial fibril-
lation and adverse cardiovascular events. Europace 2012;14:942-7.
14. Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey 
JS, et al. Atrial premature beats predict atrial fibrillation in crypto-
genic stroke: results from the EMBRACE trial. Stroke 2015;46:936-
41.
15. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and 
the risk of ischemic stroke in an ethnically mixed population. Stroke 
1999;30:2019-24.
16. Fatema K, Bailey KR, Petty GW, Meissner I, Osranek M, Alsaileek 
AA, et al. Increased left atrial volume index: potent biomarker for 
first-ever ischemic stroke. Mayo Clin Proc 2008;83:1107-15.
17. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases disper-
sion of refractoriness conducive to developing atrial fibrillation. J 
Cardiovasc Electrophysiol 1996;7:833-42.
18. Keren G, Etzion T, Sherez J, Zelcer AA, Megidish R, Miller HI, et al. 
Atrial fibrillation and atrial enlargement in patients with mitral ste-
nosis. Am Heart J 1987;114:1146-55.
19. Marcus GM, Dewland TA. Premature atrial contractions: a wolf in 
Sheep’s clothing? J Am Coll Cardiol 2015;66:242-4.
20. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Ciga-
rette smoking as a risk factor for stroke. The Framingham Study. 
JAMA 1988;259:1025-9. 
21. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking 
and cardiovascular disease: an update. J Am Coll Cardiol 2004;43: 
1731-7.
22. Chen J, Li S, Zheng K, Wang H, Xie Y, Xu P, et al. Impact of Smoking 
Status on Stroke Recurrence. J Am Heart Assoc 2019;8:e011696.
